131 related articles for article (PubMed ID: 7061024)
1. [The antigastric ulcer activity of succinic acid mono-3-guaiazulenamide (TPH-3) (author's transl)].
Kojima K; Iwano K; Nishimura H; Yoshimura A; Okuda H; Suzuki Y
Nihon Yakurigaku Zasshi; 1982 Jan; 79(1):23-32. PubMed ID: 7061024
[TBL] [Abstract][Full Text] [Related]
2. [Effects of a new histamine H2-receptor antagonist, ranitidine, on experimental acute gastric and duodenal ulcers (author's transl)].
Okabe S; Kunimi H; Ohtsuki H
Nihon Yakurigaku Zasshi; 1981 Apr; 77(4):397-406. PubMed ID: 6116654
[TBL] [Abstract][Full Text] [Related]
3. Effects of cimetidine, a histamine H2-receptor antagonist, on various experimental gastric and duodenal ulcers.
Okabe S; Takeuchi K; Urushidani T; Takagi K
Am J Dig Dis; 1977 Aug; 22(8):677-84. PubMed ID: 18007
[TBL] [Abstract][Full Text] [Related]
4. [Effects of KT1-32 on acute gastric lesions and duodenal ulcers induced in rats].
Okabe S; Takeuchi K; Mori Y; Furukawa O; Yamada Y
Nihon Yakurigaku Zasshi; 1986 Dec; 88(6):467-76. PubMed ID: 3030907
[TBL] [Abstract][Full Text] [Related]
5. [Effects of IGN-2098, a new histamine H2-receptor antagonist, on gastric secretion and gastric and duodenal lesions induced in rats. Comparison with roxatidine].
Okabe S; Narita M; Nakaji S; Takinami Y; Kawano O; Misaki N
Nihon Yakurigaku Zasshi; 1992 Mar; 99(3):167-80. PubMed ID: 1354631
[TBL] [Abstract][Full Text] [Related]
6. Effects of 5-acetylspiro[benzofuran-2(3H),1'-cyclopropan]-3-one, a new anti-ulcer agent, on experimental acute and chronic ulcers.
Inatomi N; Hirata T; Inada I; Satoh H; Sino A; Maki Y
Arzneimittelforschung; 1985; 35(10):1553-9. PubMed ID: 4074415
[TBL] [Abstract][Full Text] [Related]
7. Effects of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)-acetoxyacetamide hydrochloride (TZU-0460), a histamine H2-receptor antagonist, on gastric acid secretion and ulcer formation.
Tarutani M; Sakuma H; Shiratsuchi K; Mieda M
Arzneimittelforschung; 1985; 35(5):844-8. PubMed ID: 2862875
[TBL] [Abstract][Full Text] [Related]
8. Anti-ulcer activity of cromakalim (BRL 34915), a potassium-channel opener, against experimentally induced gastric and duodenal ulcers in rats and guinea-pigs.
Goswami S; Jain S; Santani D
J Pharm Pharmacol; 1997 Feb; 49(2):195-9. PubMed ID: 9055194
[TBL] [Abstract][Full Text] [Related]
9. Antiulcer effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl] carbamoyl]methyl]-amino-N-methylbenzamide in experimental gastric and duodenal ulcers.
Asano M; Kurebayashi Y; Ryokawa Y; Hashizume T; Akashi A
Arzneimittelforschung; 1990 Mar; 40(3):276-81. PubMed ID: 2346535
[TBL] [Abstract][Full Text] [Related]
10. Gastric antisecretory, antiulcer and cytoprotective properties of 9-hydroxy-19,20-bis-nor-prostanoic acid in experimental animals.
Valcavi U; Caponi R; Brambilla A; Palmira M; Minoja F; Bernini F; Musanti R; Fumagalli R
Arzneimittelforschung; 1982; 32(6):657-63. PubMed ID: 7202371
[TBL] [Abstract][Full Text] [Related]
11. Interferon-inducer polyriboinosinic-polyribocytidylic acid: a potent anti-gastric ulcer agent and inhibitor of the gastric proton pump in rats.
Nath C; Rastogi L; Dikshit M; Patnaik GK; Saxena RC; Gupta MB
Clin Exp Pharmacol Physiol; 1998; 25(7-8):564-7. PubMed ID: 9673429
[TBL] [Abstract][Full Text] [Related]
12. Effects of the novel anti-ulcer agent 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine on experimental ulcers and gastric secretion in rats.
Tanaka T; Bickel M; Herling AW; Sakurai M; Goto M; Hayashi S
Arzneimittelforschung; 1989 Jun; 39(6):689-94. PubMed ID: 2775336
[TBL] [Abstract][Full Text] [Related]
13. [The pharmacological studies on matrine and oxymatrine].
Yamazaki M
Yakugaku Zasshi; 2000 Oct; 120(10):1025-33. PubMed ID: 11082713
[TBL] [Abstract][Full Text] [Related]
14. Anti-ulcer and secretion-inhibitory properties of the tricyclic derivative doxepin in rats and dogs.
Leitold M; Fleissig W; Merk A
Arzneimittelforschung; 1984; 34(4):468-73. PubMed ID: 6547610
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of restraint stress by systemic (Asu1,7) eel-calcitonin.
Clementi G; Prato A; Rapisarda E; Conforto G; Mangano O; Caruso A; Scapagnini U
J Endocrinol Invest; 1985 Dec; 8(6):543-6. PubMed ID: 3833898
[TBL] [Abstract][Full Text] [Related]
16. [Studies on the anti-ulcer effects of isoprenyl flavonoids (1). The anti-ulcer effects of isoprenyl chalcone extracted from Sophora subprostrata (author's transl)].
Sasajima M; Nakane S; Saziki R; Saotome H; Hatayama K; Kyogoku K; Tanaka I
Nihon Yakurigaku Zasshi; 1978 Nov; 74(8):897-905. PubMed ID: 750329
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological properties of n1-piperonyl-n4-3,7,11-trimethyl-2,6,10-dodecatrienyl-piperazine, a new non-anticholinergic gastric antisecretory agent.
Bianchetti A; Guarneri L; Biraschi LM; Riva M
Arzneimittelforschung; 1975 Apr; 25(4):580-9. PubMed ID: 239733
[TBL] [Abstract][Full Text] [Related]
18. Effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric ulcers and gastric secretion in experimental animals.
Ueda F; Aratani S; Mimura K; Kimura K; Nomura A; Enomoto H
Arzneimittelforschung; 1984; 34(4):474-7. PubMed ID: 6540106
[TBL] [Abstract][Full Text] [Related]
19. Gastric cytoprotective, antisecretory and antiulcer activities of (E)-4-oxo-4-(3,4,5-trimethoxyphenyl)-2-butenoic acid (RU 38086).
Barzaghi F; Cesana R; Delevallée F; Fournex R; Nencioni A; Vincent JC; Deraedt R
Arzneimittelforschung; 1985; 35(9):1412-6. PubMed ID: 4084342
[TBL] [Abstract][Full Text] [Related]
20. Effects of propranolol on gastric secretion in albino rats.
Debnath PK; Gode KD; Das DG; Sanyal AK
Br J Pharmacol; 1974 Jun; 51(2):213-6. PubMed ID: 4451741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
